Tab. 1.
Clinically relevant substrates of MRP1/ABCC1 *
Type of substrates | Examples |
---|---|
Drugs | Anticancer drugs |
Vinca alkaloids: vinblastine and vincristine | |
Epipodophyllotoxins: etoposide (VP-16) and teniposide | |
Camptothecins: topotecan, irinotecan and SN-38 | |
Methotrexate and mitoxantrone | |
Other drugs | |
Anti HIV drugs; ritonavir and saquinavir | |
Antibiotics: difloxacin and grepafloxicin | |
Tyrosine kinase inhibitors: imatinib mesylate and gefitinib | |
Heavy metal anions | Arsenite |
Arsenate | |
Trivalent and pentavalent antimonials | |
Glutathione conjugates(-GS) | Dinitrophenyl-GS |
Etacrynic acid-GS | |
Doxorubicin-GS | |
Cyclophosphamide-GS | |
Melphalan-GS | |
Aflatoxin B1-epoxide-GS | |
Hydroxynonenal-GS | |
Prostaglandin A2-GS | |
Glutathione (GSH, GSSG) | |
Glucuronide conjugates (-G) | Bilirubin-G |
Estradiol 17βD-G | |
Hyodeoxycholate-G | |
Etoposide (VP-16)-G | |
NS-38-G | |
Sulfate conjugates (-S) | Estrone-3-S |
Taurocholate-3-S | |
Dehydroepiandrosterone-3-S | |
Sulfatolithocholyl taurine | |
Folates | Folic acid |
L-leucovorin | |
Toxicants | Aflatoxin B1 |
Methoxychlor | |
Fenitrothion | |
Others | Leukotrienes C4, D4 and E4 |
Curcuminoids | |
Calcein |